Advertisement
Advertisement
U.S. Markets open in 7 hrs 8 mins
Advertisement
Advertisement
Advertisement
Advertisement

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.57+0.94 (+3.98%)
At close: 04:00PM EDT
24.57 0.00 (0.00%)
After hours: 04:11PM EDT
Advertisement

Anika Therapeutics, Inc.

32 Wiggins Avenue
Bedford, MA 01730
United States
781 457 9000
https://www.anikatherapeutics.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees297

Key Executives

NameTitlePayExercisedYear Born
Dr. Cheryl Renee Blanchard Ph.D.Pres, CEO & Director1.26M27.96k1964
Mr. Michael L. LevitzExec. VP, CFO & Treasurer683.14kN/A1974
Mr. David ColleranExec. VP, Gen. Counsel & Corp. Sec.649.06kN/A1972
Ms. Anne NunesVP of OperationsN/AN/AN/A
Mr. Mark NamaroffExec. Director of Investor Relations & Corp. CommunicationsN/AN/A1963
Mr. Charles Sherwood IIIVP & Corp. Legal CounselN/AN/AN/A
Mr. James ChaseSr. VP of International Sales & MarketingN/AN/AN/A
Mr. Bart BracyVP of Sales & Marketing of AmericasN/AN/AN/A
Mr. Ben JosephVP of Commercial & Corp. Devel.N/AN/AN/A
Ms. Lisa FunicielloVP of HRN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Corporate Governance

Anika Therapeutics, Inc.’s ISS Governance QualityScore as of July 1, 2022 is 4. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 5; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement